BMF 3D biochips enable large-scale reproduction of physiologically relevant tissues.
Boston, Munich, April 30, 2024. Boston Micro Fabrication (BMF) has founded the subsidiary BMF Biotechnology Inc., which develops high-precision, microfluidic 3D biochips for pharmaceutical and cosmetic research. The organ-on-a-chip platforms enable the reproduction of physiologically relevant tissues on a large scale, thereby facilitating research into the effects of cosmetics and drugs and accelerating research processes.
BMF Biotechnology Inc., headquartered in San Diego, California, is dedicated to the development and commercialization of innovative BioChips (Organ-on-a-Chip platforms) that culture tissue in vitro on a large scale to accelerate the development of new drugs and cosmetics.
BMF develops innovative, unique high-precision microprinting platforms used by product developers and engineers in areas such as medical technology, electronics, optics/photonics and life sciences, where high resolution and demanding dimensional tolerances are required. At the end of 2022, BMF began expanding the business model beyond supplying the Projection Micro Stereolithography (PµSL) platform and the components it produces. BMF opened the San Diego Research Institute to develop innovative microfluidic biochips needed in drug research and cosmetic testing. The first phase of this effort has produced encouraging results.
By faithfully replicating the physiological conditions in the human body, BMF Biotechnology’s BioChips provide a powerful platform for studying the biological mechanisms of health and disease, assessing the safety and effectiveness of drugs and cosmetics, and predicting patient responses. BMF BioChips feature an integrated “vascular” network of channels that enable in vivo-like exchange of nutrients and wastes and delivery of substances throughout large tissues. This can lead to more precise test results and higher drug sensitivity compared to traditional 2D cell cultures and animal models.
Robust tissue models, such as tumor models for assessing drug effectiveness, kidney models for assessing drug safety, and skin models for cosmetic assessments, have been consistently developed. In addition, collaboration with global partners has led to the development of various other tissue models that help researchers better understand the biological mechanisms of health and disease, including liver and heart disease, lung cancer, cervical cancer.
“Building on the success of homegrown innovations such as UltraThineer dental veneers, the formation of BMF Biotechnology Inc. represents a major leap towards greater opportunities to harness the potential of 3D BioChip technology,” comments Dr. Jennifer Sun, Chief Scientific Officer of BMF Biotechnology Inc. “With our technology and approach, we provide researchers with innovative tools. In doing so, they quickly translate scientific discoveries into concrete therapeutic solutions that mean improvements for patients.”
In order to fully exploit the performance of the BioChips, BMF Biotechnology is now looking for cooperation partners. The partner program offers a number of opportunities to develop and validate innovative devices and biological models together with partners. We welcome it when industry, research and academic institutions approach us to explore cooperation opportunities.
For more information about BMF Biotechnology Inc. and our partner program, please visit www.bmfbio.com. You can also find us at the 2024 MPS World Summit in Booth #9, June 10-14, 2024 in Seattle, Washington.
Über BMF – Boston Micro Fabrication
Boston Micro Fabrication (BMF) enables high-precision 3D printing of micro-scale components used in healthcare, life sciences, electronics and mechanical engineering. Using the company’s proprietary PμSL (projection micro-stereolithography) technology, the printers in the microArch system produce very accurate and precise high-resolution 3D prints for product development, research and industrial small series. Founded in 2016, BMF has offices in Boston, Shenzhen, Chongqing and Tokyo, as well as a research and development center in San Diego. For more information about BMF, please visit www.bmf3d.com or follow the company on LinkedIn at
Company contact
BMF Precision Inc.
Laura Galloway
8 Mill and Main Suite 310
MA 01754 Maynard
(001)(978) 637-2050
Press contact
hightech marketing e.k.
Dr. Thomas Tosse
Inner Wiener Straße 5
81667 München
089/4591158-0
+49 89 459 11 58 11